Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
2017 · BMC Cancer · 407 citations
https://doi.org/10.1186/s12885-017-3286-5
D
Dédée F. Murrell
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
774
Papers
19.7K
Citations
68
h-index
273
i10-index
Dédée F. Murrell is an academic researcher from Sutherland Hospital. The author has contributed to research in topics: Autoimmune Bullous Skin Diseases & Skin and Cellular Biology Research & Urticaria and Related Conditions. The author has an h-index of 68, co-authored 658 publications.
ORCID: 0000-0003-2971-0199Papers by this author
worksDiagnosis and management of pemphigus: Recommendations of an international panel of experts
2018 · Journal of the American Academy of Dermatology · 356 citations
https://doi.org/10.1016/j.jaad.2018.02.021
Towards global consensus on outcome measures for atopic eczema research: results of the <scp>HOME II</scp> meeting
2012 · Allergy · 187 citations
https://doi.org/10.1111/j.1398-9995.2012.02874.x
The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers
2020 · Orphanet Journal of Rare Diseases · 166 citations
https://doi.org/10.1186/s13023-019-1279-y
Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines
2015 · British Journal of Dermatology · 150 citations
https://doi.org/10.1111/bjd.14104
Innate sensing of microbial products promotes wound-induced skin cancer
2015 · Nature Communications · 146 citations
https://doi.org/10.1038/ncomms6932
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat